The market for weight loss drugs is white-hot, and competition is heating up fast. This Danish company is already facing a ...

Modern Family’ alum Eric Stonestreet opened up to PEOPLE about living with type 2 diabetes and being unable to get a grasp on ...

Eli Lilly revenue surged in the latest quarter on steady sales of Mounjaro and other weight-loss treatments in its portfolio.

Eli Lilly said sales of weight loss drug Zepbound and diabetes treatment Mounjaro surged in the first quarter.

Eli Lilly faced a reality check as HSBC downgraded its stock twice, citing inflated optimism about its weight-loss drugs. Wall Street is underestimating the risk to Lilly from its main weight-loss ...

President Donald Trump is under pressure to decide how widely available anti-obesity drugs should be and whether Medicare ...

"GLP-1 medications are currently the most effective weight loss adjunct available if the patient does not meet the criteria ...

A daily pill could be as effective for weight loss as popular drugs like Wegovy and Ozempic, providing an alternative to the ...

Shares in Eli Lilly shot up last Thursday after the US pharma major announced positive top-line Phase III results from ...

A recent medical trial could help deliver the first daily weight loss pill capable of cutting down obesity as effectively as ...

Senior Health Correspondent for TIME, Alice Park, gives us a deeper look into how Eli Lilly's new pill orforglipron may ...

Lilly, known for injectable drugs like Zepbound for obesity and Mounjaro and Trulicity for diabetes, is among several ...